# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-050886
Filing Date
2024-05-01
Accepted
2024-05-01 07:05:31
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | amrn-20240331.htm iXBRL | 10-Q | 1837549
2 | EX-31.1 | amrn-ex31_1.htm | EX-31.1 | 11501
3 | EX-31.2 | amrn-ex31_2.htm | EX-31.2 | 11950
4 | EX-32.1 | amrn-ex32_1.htm | EX-32.1 | 11593
5 | GRAPHIC | img153232742_0.jpg | GRAPHIC | 144577
| Complete submission text file | 0000950170-24-050886.txt |  | 8495243

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | amrn-20240331.xsd | EX-101.SCH | 1261342
74 | EXTRACTED XBRL INSTANCE DOCUMENT | amrn-20240331_htm.xml | XML | 1445622

Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 24900030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)